New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...
The U.S. faces an ongoing HIV epidemic, with women, particularly women of color, bearing a heavy burden. While there have ...
The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...
Lynae Darbes, PhD, presented research on the effectiveness of a home-based intervention for HIV prevention among couples ...
An annual jab to protect against HIV “shows potential”, according to an early study. Millions of people around the world are ...
Montgomery Advertiser on MSN9h
Alabama still fighting HIV: 'In the South is where we have the majority of the problems':Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...
A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people ...
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Human rights, key and vulnerable populations Ethiopia received PEPFAR funding for work on stigma, discrimination and enabling legal environments. As a result of the USG stop-work order, all programmes ...
1don MSN
Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...
Dr. Maya Green discusses HIV prevention, addressing racial disparities in healthcare, and the powerful impact of stigma on ...
| Real-world evidence lets us see how HIV medicines work in real life, helping HCPs provide better care and improving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback